Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Better Therapeutics Inc
(NQ:
BTTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Better Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 14, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 14, 2022
November 07, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer
October 27, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes
September 22, 2022
Via
Benzinga
Why Better Therapeutics Shares Are Surging During Premarket Session
July 28, 2022
Via
Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.
Via
InvestorPlace
Positive Results from Pivotal Trial of Better Therapeutics’ Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care
October 04, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics Submits De Novo Request to U.S. FDA for BT-001 Investigational Prescription Digital Therapy for Type 2 Diabetes
September 22, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
September 20, 2022
The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...
Via
Benzinga
Bridgeline Digital And 2 Other Penny Stocks Insiders Are Aggressively Buying
September 16, 2022
The Nasdaq 100 dropped by more than 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Better Therapeutics to Participate in Three Upcoming Investor Conferences
September 07, 2022
From
Better Therapeutics
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
August 22, 2022
Good morning, investor! Let's get right into the biggest pre-market stock movers on Monday that traders will want to watch!
Via
InvestorPlace
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
August 23, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...
Via
Benzinga
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
August 22, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public...
Via
Benzinga
Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 11, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics to Release Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022
August 04, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 02, 2022
Via
Benzinga
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
August 03, 2022
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Via
Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
August 02, 2022
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End of The Day Summary
July 28, 2022
Via
Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
August 02, 2022
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
Via
Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
July 29, 2022
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 28, 2022
Via
Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
July 28, 2022
Gainers
Via
Benzinga
Why Are Hydrogen Stocks PLUG, FCEL, BE Heating Up Today?
July 28, 2022
Hydrogen stocks are climbing higher on Thursday thanks to news of Democrats reaching an agreement on climate change legislation.
Via
InvestorPlace
Why Is Better Therapeutics (BTTX) Stock Up 27% Today?
July 28, 2022
Better Therapeutics (BTTX) stock is rocketing higher on Thursday as investors react to results from a Phase 2 clinical trial.
Via
InvestorPlace
Better Therapeutics' Shares Shoot Higher Following Positive Results From Type 2 Diabetes Study
July 28, 2022
Better Therapeutics (NASDAQ: BTTX) announced positive results from its pivotal clinical trial for BT-001, prescription digital therapeutic that is designed to use nCBT to treat c diabetes (T2D).
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 28, 2022
Via
Benzinga
Better Therapeutics Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint Results Following the Earlier Announcement of Positive Primary Endpoint Results
July 28, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
Better Therapeutics to Host Conference Call to Review Results from Pivotal Clinical Trial of BT-001 for Type 2 Diabetes
July 26, 2022
From
Better Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.